Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
Paclitaxel has emerged as a front line treatment for aggressive malignancies of the breast, lung, and ovary. Successful therapy of cancer is frequently undermined by the development of paclitaxel resistance. There is a growing need to find other therapeutic targets to facilitate treatment of drug-re...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Published: |
National Academy of Sciences
2010
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/5085/ https://doi.org/10.1073/pnas.0910649107 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|